Inventor · disambiguated record
Christopher P. Meenan
Also filed as: MEENAN CHRISTOPHER · MEENAN CHRISTOPHER P
15 granted patents·2 pending applications·174 citations·filing 1998–2023
93Inventor score
Top patents by PatentIndex Score
17 records- 0191US8216822B2Bacterial host cell for the direct expression of peptidesMEHTA NOZER M·Filed 2007·Granted Jul 10, 2012·8 cites·1 claims
- 0291US6627438B2Direct expression of peptides into culture mediaUNIGENE LAB INC·Filed 2001·Granted Sep 30, 2003·21 cites·2 claims
- 0390US8835161B2Bacterial host cell for the direct expression of peptidesMEHTA NOZER M·Filed 2012·Granted Sep 16, 2014·5 cites·1 claims
- 0490US6737250B2Direct expression of peptides into culture mediaUNIGENE LAB INC·Filed 2001·Granted May 18, 2004·17 cites·8 claims
- 0590US6210925B1Direct expression of peptides into culture mediaUNIGENE LAB INC·Filed 2000·Granted Apr 3, 2001·23 cites·12 claims
- 0689US8227241B2Bacterial host cell for the direct expression of peptidesMEHTA NOZER M·Filed 2005·Granted Jul 24, 2012·6 cites·1 claims
- 0789US7553655B2Bacterial host cell for the direct expression of peptidesUNIGENE LAB INC·Filed 2007·Granted Jun 30, 2009·6 cites·1 claims
- 0889US6103495ADirect expression of peptides into culture mediaUNIGENE LAB INC·Filed 1998·Granted Aug 15, 2000·65 cites·33 claims
- 0988US8252580B2Bacterial host cell for the direct expression of peptidesMEHTA NOZER M·Filed 2007·Granted Aug 28, 2012·5 cites·1 claims
- 1086US7968311B2Direct expression of peptides into culture mediaUNIGENE LAB INC·Filed 2004·Granted Jun 28, 2011·13 cites·26 claims
- 1179US7541174B2Bacterial host cell for the direct expression of peptidesUNIGENE LAB INC·Filed 2007·Granted Jun 2, 2009·1 cites·1 claims
- 1276US10925930B2Treatment of lower urinary tract epithelium with glucagon like peptide 2URIGEN N A·Filed 2018·Granted Feb 23, 2021·2 cites·18 claims
- 1374US11491179B2Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stabilityURIGEN PHARMACEUTICALS INC·Filed 2018·Granted Nov 8, 2022·2 cites·21 claims
- 1474US2024148834A1Treatment of lower urinary tract epithelium with glucagon like peptide 2URIGEN N A·Filed 2023·Application pending·0 cites
- 1565US11850277B2Treatment of lower urinary tract epithelium with glucagon like peptide 2URIGEN N A·Filed 2021·Granted Dec 26, 2023·0 cites·17 claims
- 1659US12491207B2Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stabilityVANELTIX PHARMA INC·Filed 2022·Granted Dec 9, 2025·0 cites·17 claims
- 1727US2017189443A1Compositions and methods for treatment of diseases and conditions employing oral administration of sodium pentosan polysulfate and other pentosan polysulfate saltsPARSONS C LOWELL·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →